A revolutionary new treatment for rheumatoid arthritis. #StartActivating #SetPointSystem #SetPointTherapy Individual outcomes vary. Safety info: https://xitter.cf/t.co/BhikdgoQHO
Valencia, CA
Joined October 2013
- Tweets155
- Following42
- Followers620
- Likes35
It’s official! #SetPointSystem is now FDA approved for the treatment of rheumatoid arthritis (RA) in adults who are not adequately managed by, or who cannot tolerate, existing advanced RA therapies.
See the release: setpointmedical.com/setpoint… #Rheumatology #RheumTwitter #MedTwitter
We’re grateful to @OHSUNews for being at the forefront of exploring new therapies including the #SetPointSystem for #RA, it's helping push the field forward and expand what’s possible for patients.
Read More: news.ohsu.edu/2026/10/01/ohs…
Safety Info: spm.care/ISI
Individual outcomes vary. See important safety information at spm.care/ISI
We’re honored to be recognized on @FastCompany’s 2026 Next Big Things in Tech list as a groundbreaking technology with the potential to redefine treatment for patients with rheumatoid arthritis
Read the full release: setpointmedical.com/setpoint…
#FCTechAwards
NJ is now activated with the first #SetPointSystem procedures completed! @AtlantiCareNJ, @gni_neuro, and @AtlanticHealth together are expanding access to FDA-approved #NeuroimmuneModulation across NJ, DE & Eastern PA. Read More: setpointmedical.com/global-n…
Thank you, @CCRheumatology for a great weekend. Seeing #NeuroimmuneModulation presented as an RA treatment — and met with real enthusiasm — says a lot about where this field is headed. Learn more: healio.com/news/rheumatology…
#StartActivating #SetPointAdvantage #Rheumatology
The first patient in the Pacific Northwest has been treated with the #SetPointSystem for rheumatoid arthritis at @OHSUNews, bringing #SetPointTherapy to communities across Oregon.
Read more: setpointmedical.com/setpoint…
Individual outcomes vary. See ISI: spm.care/ISI
Join us and @USSONAR_Rh Monday, October 5th at 8:30 pm ET for a webinar with Dr. Jeffrey Curtis (UAB) to discuss vagus nerve-mediated neuroimmune modulation, a novel therapy treatment for rheumatoid arthritis.
Register today: spm.care/webinar
The first Minnesota patient has been treated with the #SetPointSystem for rheumatoid arthritis, bringing #SetPointTherapy to the Twin Cities, Rochester & surrounding communities.
Read more: setpointmedical.com/first-pa…
Individual outcomes vary. See ISI: spm.care/ISI
On @AmericaMedicine, Ken with @minnakohlermd shares his #SetPointTherapy story and tips for how he navigated new treatment options with his rheumatologist. A must-listen for people living with #RA👇
electracast.com/podcast/medi…
Individual outcomes vary. ISI: spm.care/ISI
(2/2) Indicated for use in the treatment of adults with moderately to severely active RA who have had an inadequate response, loss of response, or intolerance to one or more biological or targeted synthetic disease-modifying antirheumatic drugs. spm.care/ISI
(1/2) New on @HRheuminations: @LCalabreseDO and Dr. Chernoff explore the story behind vagus nerve’s anti-inflammatory pathways, the science of neuroimmune modulation, & the clinical journey leading to its use in rheumatoid arthritis.
Listen: spm.care/healio_107
#RA
🚨Special episode alert 🚨Rheuminations guest host @LCalabreseDO speaks with David Chernoff, MD @SetPointMed about vagal nerve stimulation and recent developments in immune mediated disease. Listen here 🎙️vist.ly/5cwhx
#Rheumatology #Podcast
We’re excited to announce that the first #SetPointSystem procedure in North Carolina was completed in collaboration with Arthritis & Osteoporosis Consultants of the Carolinas (AOCC).
Read the announcement: setpointmedical.com/arthriti…
SetPoint Medical retweeted
What began as a scientific question in the lab is now a treatment for RA patients. Congratulations to the entire @SetPointMed team for developing the innovative device to stimulate the vagus nerve inflammatory reflex, and for sponsoring and leading the clinical trials with excellence, persistence, and compassion, culminating in FDA approval.
This is a great journey in translational science, in collaboration with hundreds of people, all for the benefit of patients. Which is what the destination has been all along.
A landmark @MedEconomics study projects the #SetPointSystem could save the U.S. health system per patient over a lifetime compared to standard-of-care, with costs potentially recouped within 16 months.
Read here: setpointmedical.com/publicat…
Safety info: spm.care/ISI
We're proud to announce we've enrolled the first patients in our investigational pilot study evaluating the #SetPointSystem for relapsing-remitting #multiplesclerosis (RRMS).
Safety & effectiveness have not been established for multiple sclerosis.
#MS
setpointmedical.com/setpoint…
We’re excited to announce our partnership with @lovellgov to expand access to the #SetPointSystem across federal healthcare systems.
Safety info: spm.care/ISI
#StartActivating #Rheumatology #RA #MedTwitter
Read more: setpointmedical.com/setpoint…
Hi Dan, the SetPoint System is not available in Michigan at this time, however we are in the process of rolling out the therapy in locations across the U.S. To stay updated and be notified when there is a provider in Michigan, please submit information at: setpointmedical.com/patients…
The first #SetPointSystem procedure in California was just preformed at @DignityHealth - St. John's Regional Medical Center! Congrats to Dr. Gita Fatemi, Dr. Akinwunmi Oni-Orisan and SJRMC teams.
Get the full story: dignityhealth.org/central-co…
Safety Info: spm.care/ISI
